Xvivo Perfusion AB (OTCPK:XVIPF)

$ 42.9 1.67 (4.05%) Market Cap: 1.41 Bil Enterprise Value: 1.34 Bil PE Ratio: 67.14 PB Ratio: 7.03 GF Score: 86/100

Q3 2024 Xvivo Perfusion AB Earnings Call Transcript
Oct 24, 2024

$44.65 (-3.03%)

Earnings
Q2 2024 Xvivo Perfusion AB Earnings Call Transcript
Jul 12, 2024

$47.85 (+20.75%)

Earnings
Q1 2024 Xvivo Perfusion AB Earnings Call Transcript
Apr 24, 2024

$33.53 (+13.74%)

Earnings
Q4 2023 Xvivo Perfusion AB Earnings Call Transcript
Jan 25, 2024

$27.8 (-12.41%)

Earnings
Q3 2023 Xvivo Perfusion AB Earnings Call Transcript
Oct 24, 2023

$24.5

Earnings
Q2 2023 Xvivo Perfusion AB Earnings Call Transcript
Jul 13, 2023

$29.45 (+0.68%)

Earnings
Q1 2023 Xvivo Perfusion AB Earnings Call Transcript
Apr 24, 2023

$22.7

Earnings
Q4 2022 Xvivo Perfusion AB Earnings Call Transcript
Jan 26, 2023

$18.2

Earnings
Q3 2022 Xvivo Perfusion AB Earnings Call Transcript
Oct 27, 2022

$11.15

Earnings
Xvivo Perfusion AB Corporate Analyst Meeting Transcript
Sep 21, 2022
Q2 2022 Xvivo Perfusion AB Earnings Call Transcript
Jul 13, 2022

$21.8

Earnings
Q1 2022 Xvivo Perfusion AB Earnings Call Transcript
Apr 25, 2022

$28

Earnings
Q4 2021 Xvivo Perfusion AB Earnings Call Transcript
Jan 27, 2022

$24.85

Earnings
Q3 2021 Xvivo Perfusion AB Earnings Call Transcript
Oct 21, 2021

$39.55 (-9.50%)

Earnings
Xvivo Perfusion AB Capital Markets Day Transcript
Sep 23, 2021
Q2 2021 Xvivo Perfusion AB Earnings Call Transcript
Jul 13, 2021

$39.9

Earnings
Q1 2021 Xvivo Perfusion AB Earnings Call Transcript
Apr 21, 2021

$36.7

Earnings
Full Year 2020 Xvivo Perfusion AB Earnings Call Transcript
Jan 28, 2021

$34.6

Earnings
Q3 2020 Xvivo Perfusion AB Earnings Call Transcript
Oct 23, 2020

$28.2

Earnings
Q2 2020 Xvivo Perfusion AB Earnings Call Transcript
Jul 10, 2020

$16.9

Earnings
Q1 2020 Xvivo Perfusion AB Earnings Call Transcript
Apr 09, 2020

$10.05

Earnings
Full Year 2019 Xvivo Perfusion AB Earnings Call Transcript
Jan 30, 2020

$17.1

Earnings
Q3 2019 Xvivo Perfusion AB Earnings Call Transcript
Oct 24, 2019

$17.1

Earnings
Half Year 2019 Xvivo Perfusion AB Earnings Call Transcript
Jul 12, 2019

$20.95

Earnings
Q1 2019 Xvivo Perfusion AB Earnings Call Transcript
Apr 24, 2019

$14.4

Earnings

Q1 2019 Xvivo Perfusion AB Earnings Call Transcript

Apr 24, 2019 / 12:00PM GMT

Release Date Price: $14.4

Transcript

Operator

Ladies and gentlemen, welcome to XVIVO Perfusion Q1 Report 2019. Today, I'm pleased to present CEO, Magnus Nilsson; and CFO, Christoffer Rosenblad.

(Operator Instructions)

Please go ahead with your meeting.

Magnus Nilsson;publ;CEO;MD

Xvivo Perfusion AB

()-&

Thank you very much, and welcome to the XVIVO Perfusion Q1 report. I'm Magnus Nilsson, and again, I have Christoffer Rosenblad on my side. You have to excuse me, I caught a cold on my way here the other day from the United States. So I hope that you can hear my voice good.

Let's go to Slide #2, highlights from '19 Q1. Reimbursement process for EVLP approved in France. We see very encouraging results from the first 6 patients in the lung study with the heart preservation device. It was presented at the yearly -- the annual heart and lung transplant congress with great interest. We also have presented this device for thought-leading heart transplant surgeons worldwide, and they've shown a great interest in starting clinical trials

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.